Loading…
Formation of Hyperliquid Strategies Inc. and establishment of a crypto treasury management strategy announced.
Sonnet BioTherapeutics, Inc. and Rorschach I LLC announced on July 14, 2025 Sonnet BioTherapeutics, Inc. announced a business combination with Rorschach I LLC to create Hyperliquid Strategies Inc. and establish a crypto treasury management strategy.
The announcement cited $888 million, $583 million, $305 million, $5.5 million, $2.0 million, and 12.6 million HYPE tokens.
Sonnet BioTherapeutics Holdings, Inc. has a free float of 6,743,500 shares and 6,827,400 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.